72.7
Lantern Pharma Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
58.7
FY23:
43.3
FY24:
25.2
FY25:
10.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.23
FY22:
0.11
FY23:
0.31
FY24:
0.32
FY25:
0.23
Total assets
Change from FY21 to FY25
millions USD
FY21:
74.0
FY22:
58.8
FY23:
43.6
FY24:
25.6
FY25:
11.0
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.33
FY22:
2.80
FY23:
2.68
FY24:
4.33
FY25:
4.50
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.05
FY22:
0
FY23:
0.06
FY24:
0.05
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
71.6
FY22:
56.0
FY23:
40.9
FY24:
21.2
FY25:
6.53
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
74.0
FY22:
58.8
FY23:
43.6
FY24:
25.6
FY25:
11.0
All amounts in millions USD